SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-18-236655
Filing Date
2018-08-02
Accepted
2018-08-02 16:32:20
Documents
63
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q d511399d10q.htm 10-Q 759656
2 EX-31.1 d511399dex311.htm EX-31.1 10660
3 EX-31.2 d511399dex312.htm EX-31.2 10619
4 EX-32.1 d511399dex321.htm EX-32.1 4316
5 EX-32.2 d511399dex322.htm EX-32.2 4255
  Complete submission text file 0001193125-18-236655.txt   3738548

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT evlo-20180630.xml EX-101.INS 526941
7 XBRL TAXONOMY EXTENSION SCHEMA evlo-20180630.xsd EX-101.SCH 43090
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE evlo-20180630_cal.xml EX-101.CAL 54766
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE evlo-20180630_def.xml EX-101.DEF 171968
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE evlo-20180630_lab.xml EX-101.LAB 390783
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE evlo-20180630_pre.xml EX-101.PRE 288741
Mailing Address 620 MEMORIAL DRIVE SUITE 200 WEST CAMBRIDGE MA 02139
Business Address 620 MEMORIAL DRIVE SUITE 200 WEST CAMBRIDGE MA 02139 617 870 8281
Evelo Biosciences, Inc. (Filer) CIK: 0001694665 (see all company filings)

IRS No.: 465594527 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38473 | Film No.: 18988832
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences